Symbia_intevo_bold
Payments companies reported to CMS as associated with Symbia_intevo_bold. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Symbia_intevo_bold, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Symbia_intevo_bold
These are the largest totals companies reported as associated with Symbia_intevo_bold. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Hossein Jadvar | Los Angeles, CA | Nuclear Medicine | $3,070.66 |
| Munir Ghesani | Princeton, NJ | Nuclear Medicine | $2,400.00 |
| Julia Nguyen | Milwaukee, WI | Nurse Practitioner | $34.57 |
| Timothy Akhurst | New York, NY | Nuclear Medicine | $33.38 |
| Andres Fajardo | Indianapolis, IN | Vascular Surgery | $20.97 |
| Joseph Osborne | New York, NY | Diagnostic Radiology | $20.97 |
| Victor Hunyadi | Mount Clemens, MI | Cardiovascular Disease | $19.13 |
| Alexander Kure | Mt Clemens, MI | Cardiovascular Disease | $19.13 |
| Jay Mohan | Mount Clemens, MI | Interventional Cardiology | $19.13 |
| Brian Litch | Mount Clemens, MI | Cardiovascular Disease | $19.13 |
Prescribed Symbia_intevo_bold?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.